Sterile Prep Selected Readings: Safety in Parenteral Nutrition, Hazardous Drug Surface Contamination, Infusion-Related Phlebitis, Systematic Framework for Anticipatory Compounding (Cert# L249249)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This activity is intended for Board Certified Sterile Compounding Pharmacists in need of recertification credit. 

Board certified pharmacists are eligible to receive up to 3 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

This course is not intended for those preparing to take the BPS Compounded Sterile Preparations Pharmacy Specialty Examination for Certification.

ASHP is approved by BPS as a provider for the recertification of BCSCP.

Articles

• Mays A, Ayers P, Monczka J, Cober MP. Safety in parenteral nutrition compounding. Nutr Clin Pract. 2023; 38: 1253-1262. doi:10.1002/ncp.11064
• Hazardous Drug Surface Contamination. 2023). By Snow A, Strauss E, Gould J, Meiners M, Arnold S, Rice JN; AIHA® Healthcare Working Group. Reprinted with permission from AIHA.
• Johnson JL, Norton C, Fryfogle E, Fincher TK, Burmeister MA. The pharmacist's role in reducing infusion-related phlebitis. Am J Health Syst Pharm. 2023 Jul 21;80(15):974-983. doi: 10.1093/ajhp/zxad090. PMID: 37137335.
• Michael Toraño, Echefula Agbara, Bharat Makanji, Impact of a systematic framework for anticipatory compounding on medication waste reduction in a mid-size community hospital, American Journal of Health-System Pharmacy, Volume 81, Issue 5, 1 March 2024, Pages e122–e130.

Learning Objectives 

After participating in this CPE activity, learners should be able to:

• Demonstrate knowledge regarding the challenges of parenteral nutrition compounding, compatibility and stability of parenteral nutrition admixtures.
• Demonstrate knowledge of the factors that contribute to hazardous drug exposure for clinical and non-clinical healthcare workers.
• Demonstrate knowledge of major etiologies of infusion-related phlebitis, along with potential interventions to prevent and manage phlebitis.
• Evaluate the effect of workflow change on sterile compounding waste management.

Faculty bios

Becky Frederick, PharmD, BCSCP
Clinical Pharmacy Operations Manager
Children's Mercy
Kansas City, Missouri

Ashley Duty, PharmD, MS, BCSCP*
Clinical Pharmacy Operations Manager
Children's Mercy
Kansas City, Missouri

*Content matter expert

Angela Cassano, PharmD, BCPS, FASHP

Raymond Antypas, PharmD, MPH, BCSCP
Gina Avalone, PharmD
Amir Aziz, BCPS and BCSCP
Esraa Badran, BCSCP
Marina Beshara, PharmD, BCSCP
Tyler Billings, PharmD, BCSCP
Charles Bovell, PharmD, MPH, BCSCP
David Braverman, PharmD BCSCP
Ashlyn Carter, PharmD, BCSCP
Bryce Carter, PharmD, BCSCP
Charmaine Ch'ng, BCSCP
Letitia Cooper, PharmD, CPh, BCSCP
Jessica Darbouze, PharmD, BCSCP
Jenny Dellapietro, BS. PharmD, BCPS, BCSCP
Krystyne Douglass, Pharm D, BCSCP
Steven Getz, PharmD, BCSCP
Alexander Godwin, PharmD, BCSCP
Silva Hanissian, PharmD, PhD
Jacob Havinga, PharmD, BCSCP
Angela Gatchell Hobson, PharmD, BCSCP
Melanie Horn, PharmD, BCSCP
Maisha Khan, PharmD, BCSCP
Kyle Klawon, PharmD, BCSCP
JoAnn Koslowsky, PharmD, BCSCP
Bernard Lau, PharmD, BCSCP
Daisy Leong, PharmD
I-Chau Liang, PharmD, BCSCP, PhD
Savannah Mancuso, PharmD, BCSCP
Megan Martin, PharmD, BCSCP, SIDP-ASP
Vicki McConnell, BS Pharm, Pharm D BCPS, CPh
Pamela Meysenburg, PharmD, BCSCP
Ioana Necs, PharmD, BCSCP
Kim Nguyen, PharmD, BCSCP
Muyibat Oseni, PharmD, BCPS, BCSCP
Nima Osgo, PharmD, MBA, BCSCP
Linda Panofsky, PharmD, BCSCP
Heather Peacock, PharmD, BCSCP
Amanda Phillips, PharmD, BCSCP
Kelley Reece, PharmD, BCSCP
Jocelyn Reynoso, PharmD, BCPS, BCGP, BCSCP
Darby Rosenfeld, PharmD, BCPS BCSCP
Gina Rosito, PharmD, BCSCP
Lada Schmidt, PharmD, BCSCP
David Smith, RPh, BCSCP
Erin Stanley, PharmD, BCPS, BCSCP
Darren Stevens, PharmD, MBA, BCSCP, DPLA
Salom Suh, PharmD, BCSCP
John Thompson, PharmD, BCSCP
Kelly Tolbert, PharmD, BCSCP
Vincent Toto, PharmD, BCSCP
Shunsuke Toyoda, PharmD, BCPS, CPHQ, BCNSP, BCSCP
Morgan Walker, PharmD, MBA, BSCSP, CPH
Weihong Wang, PharmD, BCSCP
Marsha Wong, BS, PharmD, BCSCP
Danielle Zsido, PharmD, BCSCP

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

All other planners, presenters, reviewers, ASHP staff and others with an opportunity to control content report no financial relationships relevant to this activity. 

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessment
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

These activities were developed by ASHP.